New York, United States , Nov. 17, 2022 (GLOBE NEWSWIRE) -- The Global Stem Cell Market Size to grow from USD 250 million in 2021 to USD 1,027 million by 2030, at a Compound Annual Growth Rate (CAGR) of 17% during the forecast period. The stem cell therapy market has grown due to the growing number of clinical trials in stem cell therapy. In addition, the increased funding for stem cell therapies with the rise in the number of growing facilities for stem cell therapy.
Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/1297
The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic situation has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.
The allogeneic segment accounts for the largest market size during the forecast period.
Based on the type, the global stem cell therapy market is categorized into Autologous and Allogeneic. The allogeneic segment accounts for the largest market size during the forecast period. Allogeneic stem cell therapy is used excessively due to its fewer complications at the time of manufacturing the stem cell. In addition, due to this the clinical trials also increased.
The adipose tissue-derived segment to hold a higher CAGR during the forecast period.
Based on cell source, the stem cell therapy market is categorized into Adipose Tissue-Derived, MSC, Bone Marrow, and Placenta/Umbilical Cord. The adipose tissue-derived segment holds a higher CAGR during the forecast period. There are several advantages which are why this segment is dominating. Some of them are better capacity for proliferation, simple isolation processes, and minimally invasive methods.
Browse key industry insights spread across 202 pages with 135 market data tables and figures & charts from the report “Global Stem Cell Therapy Market Size, Share, and COVID-19 Impact Analysis, By Type (Autologous and Allogeneic), By Cell Source (Adipose Tissue-Derived, MSC, Bone Marrow, and Placenta/Umbilical Cord), By Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, and Neurological), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030.”, in detail along with the table of contents.
Buy Now Full Report: https://www.sphericalinsights.com/checkout/1297
The musculoskeletal segment to hold a higher CAGR during the forecast period.
Based on therapeutic application, the stem cell therapy market is categorized into Musculoskeletal, Wounds, Surgeries, Cardiovascular, and Neurological. The musculoskeletal segment to hold a higher CAGR during the forecast period. This segment is dominant due to the high prevalence of musculoskeletal disorders such as osteoarthritis. Furthermore, the demand for regenerative medicines also increases with the rise in this segment.
North America is estimated to account for the highest market share in 2021.
The Global Stem Cell Market has been segmented into five major regions: Asia-Pacific, Europe, APAC, Latin America, and MEA. Due to the rise in R&D, the strong biotechnology industry, and the presence of key players, this region dominates the market growth. In addition, increasing government initiatives also propels the market’s growth. Asia-Pacific to hold a higher CAGR during the forecast period.
Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/1297
Key Companies & Recent Developments: The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global stem cell market include Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Kite Pharma, Lonza, Cellartis AB, Angel Biotechnology, Brainstorm Cell Therapeutics, Celgene Corporation, Osiris Therapeutics, Genea Biocells, Bioheart Inc., Waisman Biomanufacturing, Tigenix, Caladrius Biosciences, Gamida Cell and others 20+ prominent key players we have added in the final report. Global Economy: Recession Risk Rising Analysis and Russia-Ukraine Conflict War Impact we have added in the report.
Discount Price: https://www.sphericalinsights.com/request-discount/1297
Browse Related Reports
Global T-Cell Lymphoma Market Size, Share, and COVID-19 Impact Analysis, By Type of Lymphoma (Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angio-immuno-blastic T-cell Lymphoma, and Other Types of Lymphoma), By Type of Therapy (Radiotherapy, Chemotherapy, Immunotherapy, Stem Cell Transplantation, and Other Types of Therapies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.
https://www.sphericalinsights.com/reports/t-cell-lymphoma-market
Global Lentiviral Vectors Market Size, Share, and COVID-19 Impact Analysis, By Component (Lentiviral promoter, Lentiviral fusion tags, Lentivirus packaging systems and Other), By Type (Product and Services), By Generation (4th-generation, 3rd-generation, 2nd-generation and 1st-generation), By Workflow (Upstream Processing And Downstream Processing), By Delivery Method (In Vivo and Ex Vivo), By Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease And Other), By Application (Gene Therapy And Vaccinology), By End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030.
https://www.sphericalinsights.com/reports/lentiviral-vectors-market
CONTACT US
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
